Share Name Share Symbol Market Type Share ISIN Share Description
Totally Plc LSE:TLY London Ordinary Share GB00BYM1JJ00 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -1.35% 18.25 58,214 13:28:00
Bid Price Offer Price High Price Low Price Open Price
18.00 18.50 19.225 18.25 18.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 105.95 -3.41 -1.82 33
Last Trade Time Trade Type Trade Size Trade Price Currency
10:39:26 O 15 18.98 GBX

Totally (TLY) Latest News

More Totally News
Totally Investors    Totally Takeover Rumours

Totally (TLY) Discussions and Chat

Totally Forums and Chat

Date Time Title Posts
25/11/202016:43Totally Health - 2014 onwards16,625
25/11/202015:25Don't forget the warrants !!. (Co. runs for the directors imho)140
16/11/202021:28totally disinterested??41
13/11/202008:11Totally - Supporting the NHS14
18/5/202021:35Feeling Better?568

Add a New Thread

Totally (TLY) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Totally trades in real-time

Totally (TLY) Top Chat Posts

Totally Daily Update: Totally Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker TLY. The last closing price for Totally was 18.50p.
Totally Plc has a 4 week average price of 17p and a 12 week average price of 16.88p.
The 1 year high share price is 25.50p while the 1 year low share price is currently 9.15p.
There are currently 182,186,111 shares in issue and the average daily traded volume is 511,794 shares. The market capitalisation of Totally Plc is £33,248,965.26.
gbcol: I think the presentation was good and definitely worth tuning in for. Maybe they are not slick, polished performers but actually that can help as you don't get the usual corporate speak and BS. Yes they are very proud of what they are doing and how the business is doing. Nothing wrong with that IMO. Judging by the amount of notes I took, it can't just have been all waffle (acknowledge that debt explanation was waffle though and not much wiser other than it includes stuff like potential but unknown about malpractice claims that could occur in future although may not crystalise). A few of my take-aways:- No appetite in NHS for rebidding which means that contracts are just rolling over, with ALL extra work being paid for Urgent care currently 96% of revenues and doing very well Involved in various pilots with NHS which in terms of 111 has led to TLY process being accepted as NHS gold standard that other companies will have to meet Order book for Insourcing increasing above their expectations Keen on proactively growing revenues. 111 a big growth area. Frustrated by share price performance and no explanation. No expectation of doing share buybacks (advised not to do it just to support SP) Not looking at any significant acquisitions and so no plans for cash raise. Could do small bolt ons if appropriate eg technology Planned care not really affected by 2nd lockdown (unlike 1st one where it stopped). Currently running at 85% capacity. Intention of board to carry on with divi policy although not move to a progressive divi until we are through current uncertainties. All IMO and to the best of my recollection, but feel free to comment if I have mis-interpreted anything. For what it's worth, I have been adding at current levels recently and consider anything sub-18p as a steal, although TBH I've probably got plenty for my needs now!
phil mcavity: I made a note a few months ago that somebody here mentioned that Mears Group would prove to be a real winner ~~~ Well Done ! Whoever that was must be enjoying their decision . Meanwhile here at TLY I hope there will be a statement on Monday that supports our confidence in staying with the Company through this interesting period . If they make the right noises I think the share price will spike upward , if they don`t , I suppose we`ll be stuck around here until they do ! I`m not selling because this is a well run , under valued (30 M mkcap !), divi paying AIM Company with real growth potential ~~~ AND ~~~ The Hunter could easily become the Hunted ! GLA .
assagai: Thanks Graham, yes I fully appreciate the trade "colours" and timings. That said it still remains the case that all the 3 largish tradrs were dealt below the mid price at the time which on average would suggest sells. I have bought various stocks (over the decades) below mid but it is the exception not the rule . That said all SETS stocks suggest a different logic as someone has to offer the shares for sale before they can be bought and vice versa. You obviously have better knowledge of the company specifics than I, for reasons of optimism hope your analysis is correct. BTW I remain mystified at the apparently superb value but stuck nature of the share price
grahamwales: Assagai Colours of trades mean very little on AIM, best to look at prices before and after to see if you think they are buys or sells. With Miton selling a few my guess is that someone has picked up those sells so probably about even for trades. Without the likes of Miton TLY would not have been able to expand so they bought at 10p and selling some at around 18p. Someone is buying at 18p and will want to sell some at 25p. It’s up to the company to keep increasing profits and pay more in dividends to keep the share price moving up.
sikhthetech: graham, Interesting about Medefer. They do seem to have a business which would fit nicely with TLY Urgent Care division. I wouldn't say they are out of TLY's reach. TLY could follow their previous acquisition strategy which Bob used at Mears and here - pay some upfront and the remaining as performance related payments in the futur In terms of recruiting some tech guys, TLY had a division, "Totally Communications", which was sold off years ago. I would have thought the current BoD still have contact with them, eg Andrew Margolis is still a director there. This maybe an alternative to buying Medefer.
sikhthetech: savaged, 1) TLY have acquired several companies over the past 3 yrs as part of their "Add and Build" strategy. They are not reacting to Covid and setting up NHS 111 now. NHS 111 was promoted as the first port of call for anyone with Covid symptoms. The fact TLY had the system up and running shows they are ahead of the game and not looking in the mirror. This is evident by the fact they was significant demand for NHS 111. The govn are looking at using NHS 111 to triage patients before going to A&E. That's not new. The govn have wanted to use NHS 111 to reduce A&E waiting times for years. Covid has simply brought the agenda forward. That is even better for TLY, as there should be larger contracts. TLY are well positioned to seize any opportunities. TLY have a diversified business setup which was evident because they were able to quickly adapt to NHS requirements. This diversified business model also meant that weaker demand for Planned Care was offset by Stronger demand for Urgent Care. 2) Why would a milder flu season have any effect on NHS 111 contracts? NHS 111 provides multiple services. Pharmacies & GPs have handled flu symptoms perfectly well for years. 3) Nothing to do with TLY. 4) TLY should invest in AI & Machine learning for NHS 111. That's rubbish. Why? TLY supports the NHS. It is the NHS who provide the NHS 111 & 999 Pathway system not TLY. NHS introduced NHS 111 website for Covid to ease the pressure on phone lines. TLY have had the foresight to setup their business to support NHS requirements and to adapt to them very quickly. Their Planned Care, Urgent Care and Insourcing Divisions provide a very diversified business.
sikhthetech: Over the past 4 yrs TLY has grown significantly as can be seen from their results. This was achieved as part of their Add and Build strategy. period revenue, cash, profit/loss 2015 £0.6m, £0.4m, £0.4m 2016 £4m, £1m, £1.4m 2017 £21.3m, £11.3m, £5.6m 2018 £42m, £10.2m, £0.2m 2019 £78m, £7.5m, £1.1m 2020 £105m, £8.9m, £4m Gross margins up Paying dividends. Wendy has decades of experience within NHS & Healthcare settings. Bob has decades of experience with the markets & IIs. Today TLY is a diversified business and as can be seen over the past 6 months, 1 division, Urgent Care, has been growing strongly. Vocare & Greenbrook were bought over the past 3 yrs. TLY have the right business mix and are in the right place at the right time. The govn is pushing NHS 111 as the 1st point of contact to reduce GP appts & A&E waiting times. TLY are a national provider for this and hav Read the company and Healthcare newsflow.
hodhasharon: Share Price vs. Fair Value 84.1% Undervalued Current Price UK£0.18 Fair Value UK£1.15 Below Fair Value: TLY (£0.18) is trading below our estimate of fair value (£1.15) Significantly Below Fair Value: TLY is trading below fair value by more than 20%.
napoleon 14th: I like the statement, but IMO it needs more figures; eps/ebitda etc... Turnover is vanity, profit is sanity & cashflow is REALITY. TLY is doing fine on that, & share price should rise when figures show TLY's progress. I hold quite a few & won't sell any.
hodhasharon: Share Price vs. Fair Value 82.8% Undervalued Current Price UK£0.20 Fair Value UK£1.15 Stable Cash Runway: Whilst unprofitable TLY has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level. Ownership Breakdown General Public 7.6% 13,887,397 shares Individual Insiders 23.9% 43,485,380 shares Institutions 68.5% 124,813,334 shares
Totally share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201126 14:32:05